BioNTech SE
BNTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001776985
In the last 90 days, BioNTech SE insiders filed 0 open-market purchases and 10 sales; 283 institutions reported holding it in 13F filings for Q2 2026, worth $4.36B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q2 2021
Institutional positions in BioNTech SE as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 284
- +58 vs. Q1 2021
- Shares held
- 34.9M
- +5.06M (+16.9%) vs. Q1 2021
- Total value
- $7.84B
- +$4.59B (+141.0%) vs. Q1 2021
- New holders
- 95
- 72 more added
- Sold out
- 37
- 81 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BNTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 283 | $4.36B |
| Q1 2026 | 274 | $4.22B |
| Q4 2025 | 285 | $4.56B |
| Q3 2025 | 254 | $4.97B |
| Q2 2025 | 258 | $5.72B |
| Q1 2025 | 279 | $4.71B |
| Q4 2024 | 303 | $5.79B |
| Q3 2024 | 297 | $5.24B |
| Q2 2024 | 286 | $3.30B |
| Q1 2024 | 287 | $3.78B |
| Q4 2023 | 282 | $4.28B |
| Q3 2023 | 252 | $4.01B |
| Q2 2023 | 253 | $4.05B |
| Q1 2023 | 282 | $4.88B |
| Q4 2022 | 320 | $5.97B |
| Q3 2022 | 264 | $5.01B |
| Q2 2022 | 293 | $4.99B |
| Q1 2022 | 286 | $5.90B |
| Q4 2021 | 355 | $9.08B |
| Q3 2021 | 336 | $10.0B |
| Q2 2021 | 284 | $7.84B |
| Q1 2021 | 226 | $3.25B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding BioNTech SE; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −5,046−100.0% | Sold out |
| Pentwater Capital Management LP | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Enlightenment Research, LLC | 0 | $0 | 0.00% | −4,400−100.0% | Sold out |
| Voya Financial Advisors, Inc. | 0 | $0 | 0.00% | −4,504−100.0% | Sold out |
| Moneta Group Investment Advisors LLC | 0 | $0 | 0.00% | −4,286−100.0% | Sold out |
| Harvest Investment Services, LLC | 0 | $0 | 0.00% | −3,097−100.0% | Sold out |
| Acorn Financial Advisory Services Inc | 0 | $0 | 0.00% | −1,974−100.0% | Sold out |
| SG3 Management, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Grandview Asset Management LLC | 0 | $0 | 0.00% | −750−100.0% | Sold out |
| Valeo Financial Advisors, LLC | 0 | $0 | 0.00% | −644−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −322−100.0% | Sold out |
| John W. Brooker & Co., CPAs | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Eudaimonia Partners, LLC | 0 | $0 | 0.00% | −225−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −62−100.0% | Sold out |
| TFC Financial Management | 0 | $0 | 0.00% | −53−100.0% | Sold out |
| Sound Income Strategies, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Manchester Financial Inc | 0 | $0 | 0.00% | −48−100.0% | Sold out |
| Adirondack Trust Co | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Salem Investment Counselors Inc | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Annapolis Financial Services, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −3−100.0% | Sold out |